B
Biofourmis
ListedAI-powered health analytics and virtual care platform for proactive and personalized patient care.
Detailed overview
## Overview
Biofourmis is a health technology company that partners with healthcare organizations and life science companies to provide technology-enabled solutions for care delivery and drug development. The company focuses on expanding access to care, particularly by enabling care in the home setting. Their platform integrates connected technology, data analytics, and clinical support to manage patients across various care settings.
Biofourmis's solutions aim to improve clinical, operational, and economic outcomes for healthcare providers and enhance the patient experience by offering continuity of care and more care options. They support the entire care continuum, from drug development to post-acute care management.
## Key Features
* **Connected Technology Platform:** Biofourmis utilizes a platform that integrates various technologies to facilitate remote patient monitoring and care delivery.
* **Care Delivery Solutions:** The company offers solutions that enable different models of care, including Hospital at Home, Timely Discharge, Skilled Nursing Facility (SNF) at home, and Remote Patient Management.
* **Drug Development Support:** Biofourmis collaborates with life science companies to support drug life cycle management and clinical trials.
* **AI-driven In-Home Care:** Through a merger with CopilotIQ, Biofourmis offers an end-to-end platform for AI-driven in-home care.
* **Clinical and Operational Outcomes:** The platform is designed to contribute to outcomes such as reductions in 30-day readmissions, earlier detection of patient deterioration, and reductions in the cost of care.
* **Partnerships:** Biofourmis partners with health systems, hospitals, payers, and risk-bearing organizations.
## Who It's For
* **Health Systems and Hospitals:** Organizations looking to implement or expand acute care-at-home programs, remote patient monitoring, and improve patient transitions across care settings.
* **Payers and Risk-Bearing Organizations:** Entities seeking to manage patient populations, reduce healthcare costs, and improve outcomes through technology-enabled care models.
* **Life Science Companies:** Organizations involved in drug development and clinical trials that require technology solutions for patient monitoring and data collection.
* **Providers aiming for value-based care:** Healthcare providers focused on improving efficiency, patient outcomes, and economic performance.
## Notable Strengths
Biofourmis demonstrates capabilities in extending care into the home, supported by reported outcomes such as a 70% reduction in 30-day readmissions and the ability to detect deterioration 21 hours sooner. Their platform supports a range of care models, from acute care at home to remote patient management. The company has established partnerships with over 50 global health systems and payers, indicating a broad reach and adoption of their solutions. The merger with CopilotIQ suggests an emphasis on integrating AI into their in-home care offerings. Biofourmis operates with licensed operations in 25 U.S. states.
Website link is available on the Verified plan
